Buy
Sell
Share Name Share Symbol Market Type Share ISIN Share Description
Maxcyte Inc LSE:MXCT London Ordinary Share COM STK USD0.01 (DI)
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -90.00 -9.47% 860.00 880.00 900.00 960.00 890.00 960.00 88,092 16:35:24
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Pharmaceuticals & Biotechnology 16.3 -9.7 -17.3 - 639

Maxcyte Share Discussion Threads

Showing 576 to 598 of 600 messages
Chat Pages: 24  23  22  21  20  19  18  17  16  15  14  13  Older
DateSubjectAuthorDiscuss
05/3/2021
10:42
MXCT presenting at proactive next week: hTTps://event.webinarjam.com/register/945/5vv20b3vp?j=698606&sfmc_sub=207589499&l=86_HTML&u=38515100&mid=100009383&jb=80
homebrewruss
05/3/2021
09:37
Could easily slip to 760p where the 200d mva is. A great co but one has to see the valuation downward adjustments occurring globally in the biotech, life sciences area...
montynj
04/3/2021
14:19
This is the cannabis stock to be in ANA - will be producing 200 TONS !!! 50% shares held by 4 people 30% by BOD £6m mkt cap Share price 1.1p hTTps://www.aquis.eu/aquis-stock-exchange/for-investors/announcements?view_news_id=387879 hTTps://www.aquis.eu/aquis-stock-exchange/for-investors/announcements?view_news_id=535389
gordan ghetto
03/3/2021
10:52
New product 'VLX' being launched in 2021 (from 19 minutes) hTTps://wsw.com/webcast/cowen81/mxct/1973772 hTTps://twitter.com/pepersoons/status/1367049668660776960
homebrewruss
03/3/2021
07:18
its on there now hTTps://maxcyte.com/corporate-presentations/
nimbo1
02/3/2021
10:17
Don't see yesterday's presentations yet. Thought it was going on the website? Maybe too soon...
assagai
27/2/2021
10:00
As a rule of thumb decent hedge funds only buy things like maxcyte if they think they can double their money. (They are not always right of course!) So d1 in at 7 means they expect 14 within 24 months and maybe more. Very crude but may as well keep it simple. I’m happy to ride out volatility too - it’s the only way to make it big and this should become a long term high growth compounding champion.
nimbo1
26/2/2021
23:31
Interesting today, the long overdue retrace was very quickly turned back on itself. So many other investments (hydrogen sector etc, that have had meteoric rises) have become very volatile ,with significant pull backs. After 500 % gain over the last year this seems very solid. As nimbo has flagged it seems quite a few shares have passed from satisfied hands to enthusiastic new ones. In today's climate the prospect of a share doubling in value is hard to resist, so let's ignore the gain to date and look upon this as a new investment we would like to see double, or maybe even better over the next year. If the potential for cash generation is even partially realised would it not be unreasonable to be expecting dividends in the future. On £20 plus a five % yield would be great but on an average of maybe £3 or £4 , the returns would be spectacular! So happy to break my golden rule and not take any profits,...at all. Warren Buffet isn't called the sage for nothing.
assagai
26/2/2021
15:23
Nope. Very long :)
nimbo1
26/2/2021
13:26
its good to have a fall, much needed consolidation going on - given all the large buys over the past 5 days (showing great institutional demand) will be interesting to see where it finds its level in the tricky market!
nimbo1
24/2/2021
14:29
Positive article with comments from James Brady Maxctye Vice President, Technical Applications and Customer Support hTTps://biobuzz.io/cell-and-gene-therapys-future-a-complex-mix-of-promise-and-pitfalls/
pob69
23/2/2021
07:47
Fingersxxxxd
assagai
23/2/2021
07:39
As these conference presentations are advertised as Corporate (rather than Clinical), I'm hoping they will coincide with the formal start of the Nasdaq application process.
someuwin
23/2/2021
07:33
https://www.google.com/url?rct=j&sa=t&url=https://www.fox8jobs.com/jobs/electromechanical-assembler-gaithersburg-maryland/234931826-2/&ct=ga&cd=CAEYACoUMTE4Mzg5NDY2NjkwNDUxMDUzODcyHDY0NjJhNDU2NjA4NmZhYTA6Y28udWs6ZW46R0I&usg=AFQjCNFumR_rVz67yC6sVyL7btDADfAy_Q
assagai
23/2/2021
07:05
MaxCyte, Inc. 22 February 2021 FOR IMMEDIATE RELEASE MaxCyte to Participate in Two Upcoming Virtual Healthcare Investor Conferences GAITHERSBURG, MD, February 23, 2021 - MaxCyte, Inc., a global cell-based therapies and life sciences company, today announced two upcoming presentations at virtual healthcare investor conferences. Details are as follows: Cowen 41st Annual Health Care Conference Who: Doug Doerfler, President & Chief Executive Officer, and Amanda Murphy, Chief Financial Officer, will present a corporate overview Dates: Virtual conference March 1 - 4, 2021 MaxCyte Presentation Details: March 1, 1:20 - 1:50 p.m. ET An archived version of the presentation will be made available following the conference in the Investors section of the Company website H.C. Wainwright & Co Global Life Sciences Conference Who: Doug Doerfler, President & Chief Executive Officer, will present a corporate overview Dates: Virtual conference March 9 - 10, 2021 MaxCyte Presentation Details: Available on demand to conference participants March 9 - 10, 2021
someuwin
22/2/2021
12:34
Interesting to note that Ark Genomic Revolution has bought into the CM Life Sciences SPAC which takes it a step closer to MXCT Crossover investor, and CM Life Sciences founding investor, Casdin Capital
rgmgo
22/2/2021
11:35
You are right Tom and I mentioned it at the time of the raise - D1 getting involved will have made other US institutions look - what is happening is UK institutions are trimming and US ones are buying imo. Very happy if it continues to consolidate up here because I was expecting more volatility given market conditions and the gains some people have already enjoyed.
nimbo1
22/2/2021
11:01
Huge trade volume continuing today - clearly the £10 level is the going rate for institutions to exchange millions of pounds of shares. Once this hits NASDAQ and gets discovered I agree it'll be multiples of the current level very quickly indeed, you simply wouldn't have this level of interest unless the technology AND commercial agreements offered an exceptional opportunity.
74tom
20/2/2021
18:47
Perfectly put Charlie. You will find the naysayers are as usual, those who missed the boat. I was one of those fortunate enough to get in before the start of the rise and any company that can make me 7figures in a year is welcome to their options. All I would say is that we are not even half way to where I think we will go over the next year or so.
assagai
20/2/2021
18:12
So it's OK for shareholders who do nothing to run a company to profit from other peoples work, but not for those who create wealth and work harder than I suspect you have an idea of to not? Weird world you must inhabit. They have stolen nothing. They have made anyone who joined this party cash - and significant cash to those who looked hard at MXCT as an investment in early days.
charliec51
19/2/2021
18:57
Looks like they’ve earned it to me
eaglebeagle
19/2/2021
18:16
I don't recall many complaints a year ago about options?
trickydicky1
19/2/2021
15:52
This chap Will Brooke just stole £415,135 pounds rightfully belonging to all shareholders, by issuing himself 40900 shares at whatever price and selling it on straight away at £10.15share. Clearly he must supplement his meagre earnings with this stolen freebee, which should be available to all shareholders at a similar proportion. The options of directors being able to issue themselves vast and unearned wealth should be abolished!
a1samu
Chat Pages: 24  23  22  21  20  19  18  17  16  15  14  13  Older
ADVFN Advertorial
Your Recent History
LSE
MXCT
Maxcyte
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20210306 09:41:00